ALGN Stock Forecast: Align Technology, Inc. Price Predictions for 2026-2027
The 16 Wall Street analysts covering Align Technology, Inc. hold a median 12-month price target of $191 — +22.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 83 of 100 as at 21 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Align Technology, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (96): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Revisions (43): Analysts have, on balance, been cutting their forecasts.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
ALGN stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on ALGN, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +22.7% from it.
Of the 20 most recent actions, 1 moved their price target up and 8 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 29 Oct 2026 | Leerink Partners | Maintains | Outperform | $215 → $210 |
| 29 Oct 2026 | Morgan Stanley | Maintains | Equal-Weight | $188 → $175 |
| 22 Oct 2026 | Mizuho | Maintains | Outperform | $220 → $200 |
| 21 Oct 2026 | Piper Sandler | Maintains | Overweight | $235 → $205 |
| 15 Oct 2026 | Baird | Downgrade | Neutral | $218 → $162 |
| 14 Oct 2026 | Leerink Partners | Maintains | Outperform | $235 → $215 |
| 9 Oct 2026 | Stifel | Maintains | Buy | $210 → $175 |
| 5 Oct 2026 | Evercore ISI Group | Downgrade | In-Line | $220 → $155 |
| 23 July 2026 | UBS | Maintains | Neutral | $186 → $189 |
| 9 July 2026 | BMO Capital | Initiates | Outperform | $209 |
| 30 Apr 2026 | Evercore ISI Group | Maintains | Outperform | — |
| 30 Apr 2026 | Mizuho | Maintains | Outperform | — |
| 24 Apr 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 21 Apr 2026 | Piper Sandler | Maintains | Overweight | — |
| 15 Apr 2026 | Citigroup | Initiates | Buy | — |
| 17 Mar 2026 | Barclays | Upgrade | Overweight | — |
| 26 Feb 2026 | Barclays | Maintains | Equal-Weight | — |
| 9 Feb 2026 | HSBC | Upgrade | Buy | — |
| 5 Feb 2026 | Evercore ISI Group | Maintains | Outperform | — |
| 5 Feb 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for ALGN.
This page is one stock. Monday covers all of them.
ALGN appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
ALGN vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, Align Technology, Inc. returned +16.9% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
ALGN analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 22.6×
- Price / sales
- 2.6×
- Price / book
- 2.5×
- EV / EBITDA
- 10.3×
Cheaper than 40% of US stocks
Cheaper than 41% of US stocks
Cheaper than 35% of US stocks
Cheaper than 55% of US stocks
- Revenue growth (YoY)
- 1.9%
- Earnings growth (YoY)
- 138.0%
- Gross margin
- 71.7%
- Operating margin
- 19.6%
- Net margin
- 11.8%
Higher than 32% of US stocks
Higher than 87% of US stocks
Higher than 84% of US stocks
Higher than 79% of US stocks
Higher than 71% of US stocks
- Return on equity
- 11.9%
- Return on assets
- 8.0%
- Dividend yield
- —
Higher than 67% of US stocks
Higher than 87% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Align Technology, Inc. has a market value of $10.9B and an enterprise value of $9.9B.
Revenue in the twelve months to 30 June 2026: $4.1B. The latest quarter grew 4.3% year on year.
Net income over the same four quarters: $413.6M, a 10.0% net margin.
Diluted earnings per share, trailing twelve months: $5.75.
Free cash flow in the twelve months to 30 June 2026: $633.6M.
Align Technology, Inc. spent $266.9M on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 22.6×; forward P/E: 12.6× — the forward figure prices analyst consensus estimates, not reported earnings.
Align Technology, Inc. employs 20,180 people — $205K of revenue per employee.
Data provided by Twelve Data
ALGN and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at ALGN’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Align Technology, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about ALGN
What is the ALGN stock price forecast for 2026-2027?
The 16 Wall Street analysts covering Align Technology, Inc. have a median 12-month price target of $191, with estimates ranging from $160 to $210. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is ALGN stock a buy right now?
Of the 16 analysts covering Align Technology, Inc., 7 rate it a Buy, 8 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Align Technology, Inc. 83 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank ALGN?
As at 21 Nov 2026, Align Technology, Inc. ranks 83 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Value (96 of 100).
Will ALGN stock go up?
No one can know that. What the data says: the median 12-month target from 16 analysts implies +22.7% from the last close, and Ticker Nerd's factor model ranks Align Technology, Inc. 83 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the ALGN stock forecast for 2030?
No analyst covering Align Technology, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ALGN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $160 to $210 over the next 12 months.
How has ALGN stock performed over the past year?
Align Technology, Inc. returned +16.9% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Align Technology, Inc. do?
Align Technology Inc. is a medical device company focused on digital orthodontics and restorative dentistry. The company develops and markets the Invisalign clear aligner system, Vivera retainers, and a range of intraoral scanning and digital treatment-planning tools used by dental professionals.
About Align Technology, Inc.
Align Technology Inc. is a medical device company focused on digital orthodontics and restorative dentistry. The company develops and markets the Invisalign clear aligner system, Vivera retainers, and a range of intraoral scanning and digital treatment-planning tools used by dental professionals. Its iTero scanners and related services support precise imaging, workflow efficiency, and chairside communication in orthodontic and general dentistry practices. Align Technology also offers exocad CAD/CAM software, extending its presence across dental design and fabrication workflows. The company serves dentists, orthodontists, and dental laboratories in markets around the world, with products designed to support treatment planning, patient monitoring, and restorative procedures. Align Technology plays a central role in the shift from traditional braces and analog dental processes to connected, software-enabled oral healthcare solutions.
CEO Mr. Joseph M. Hogan · 20,180 employees · United States · https://www.aligntech.com